Group 1: Influenza Situation - The influenza activity in China has reached an epidemic level, with most provinces reporting a rapid increase in cases [1] - The latest report indicates that flu-like cases in sentinel hospitals have reached the highest proportion in nearly four years, with northern provinces showing higher rates than southern ones [1] - A total of 955 flu-like outbreaks were reported nationwide, with 741 caused by the H3N2 strain [1] Group 2: Stock Market Overview - The U.S. stock market experienced gains, with the Dow Jones Industrial Average rising by 314.67 points, or 0.67%, to close at 47,427.12 points [2] - The S&P 500 and Nasdaq also saw increases of 46.73 points (0.69%) and 189.1 points (0.82%), respectively [2] - Retail stocks strengthened ahead of the Black Friday shopping season, with Walmart reaching a historic high [2] Group 3: Hong Kong Real Estate Market - The private residential property price index in Hong Kong rose by 0.4% in October, marking five consecutive months of increases [3] - The latest index does not yet reflect the positive impacts of recent interest rate cuts and significant agreements reached during the U.S.-China summit [3] Group 4: Financial Innovations - The Industrial and Commercial Bank of China has successfully conducted offshore foreign currency tri-party repurchase transactions, becoming the first domestic bank to participate in this international market [4] - This innovation enhances the bank's pricing power and operational efficiency while reducing risks and costs associated with traditional bilateral repurchase agreements [4] Group 5: AI Product Launch - Meituan has launched its first AI IDE product, CatPaw, which focuses on agent-driven programming and includes features like code completion and project debugging [5] Group 6: Pharmaceutical Approvals - Boan Biotech's Abicipar injection has received approval for marketing in China, targeting age-related macular degeneration and diabetic macular edema [6] - Eucan Vision Biotech's OT-702, a biosimilar to EYLEA, has also been approved for the same indications in China [7] Group 7: Financial Performance - Haidilao's overseas business reported a revenue of $214 million for Q3, reflecting a year-on-year growth of 7.8% [8] - Yao Cai Securities reported a net profit of HKD 327 million for the six months ending September 30, marking a 4.77% increase year-on-year [9] - NIO's Q3 revenue reached RMB 21.79 billion, with a strong delivery growth of 40.8% year-on-year, and a Q4 revenue guidance of RMB 32.758 billion to RMB 34.039 billion [10] Group 8: Debt Restructuring - Ocean Group's debt restructuring plan for seven domestic bonds, totaling approximately RMB 13.05 billion, has been approved by bondholders [11] Group 9: New Stock Performance - The new Hong Kong stock Quantitative Party saw a nearly 200% increase in its dark market trading, reflecting strong investor interest [12] Group 10: Company Earnings - Alibaba Health reported a net profit of RMB 1.266 billion for the six months ending September 30, a 64.7% increase year-on-year, with total revenue of RMB 16.697 billion [13]

Core Viewpoint - Ant Group has extended the deadline for its acquisition offer for Yao Cai Securities by four months to March 25, 2026, while increasing the deposit from HKD 140 million to HKD 164 million, which is 5.83% of the total transaction value. The completion conditions for the transaction have not yet been fully met, leading to uncertainty regarding the final outcome [1][3]. Group 1 - On April 25, Yao Cai Securities announced that Ant Group, through its subsidiary Ant Wealth, made a takeover offer at HKD 3.28 per share for approximately 858 million shares, representing about 50.55% of the total issued shares, amounting to HKD 28.14 billion. If successful, this would result in a change of control to Ant Group [3]. - On October 10, the acquisition was further advanced as Yao Cai Securities announced that the Hong Kong Securities and Futures Commission had approved the acquisition, pending approval from the National Development and Reform Commission [3]. - Following the announcement of potential delays in the acquisition on November 11 due to incomplete regulatory approvals, Yao Cai Securities experienced a significant stock price increase of 34.52% [3]. Group 2 - Financial data for Yao Cai Securities shows total revenue for the fiscal years 2022 to 2024 as HKD 1.014 billion, HKD 1.050 billion, and HKD 1.121 billion, with year-on-year changes of -19.96%, -4.05%, and 3.09% respectively. Net profit attributable to shareholders for the same period was HKD 455 million, HKD 543 million, and HKD 506 million, with year-on-year changes of -20.23%, 10.53%, and -9.95% respectively [4].

本文源自：金融界AI电报 耀才证券金融(01428.HK)发布截至2025年9月30日止六个月的中期业绩，收入4.97亿港元，同比增长 10.72%;净利润3.27亿港元，同比增长4.77%;基本每股盈利19.26港仙。 ...

格隆汇11月26日丨耀才证券金融(01428.HK)公告，截至2025年9月30日止6个月中期业绩，集团收入录得 4.97亿港元，较去年同期上升10.7%；而股东应占税后纯利为3.27亿港元，较去年同期上升4.8%；本期 间每股盈利为19.26港仙(2024年：18.38港仙)。 集团多年来都会按市况及时调整市场及营运策略，灵活应对。集团预见客户对网上交易渠道(手机应用 程式(APP)及网上平台)及网络安全的需求日益增长并高度重视，因此，集团每年均会斥巨资提升手机交 易平台系统－"耀才证券(宝宝)"及"耀才期货(豆豆)"手机应用程式(APP)的功能，确保各系统功能与时并 进。集团亦持续完善应用程式的性能，并取得卓越成效，推出至今已吸引近三十万用户下载。 未来，集团将继续投放大量资源，致力优化网上交易渠道及服务质素，并提升网络安全措备，进一步保 障客户利益。同时，集团随时为市场波动作好准备，迎接挑战，捉紧机遇。 ...

耀才证券金融(01428)发布截至2025年9月30日止六个月的中期业绩，收入4.97亿港元，同比增长10.72%; 净利润3.27亿港元，同比增长4.77%;基本每股盈利19.26港仙。 ...

智通财经APP讯，耀才证券金融(01428)发布截至2025年9月30日止六个月的中期业绩，收入4.97亿港 元，同比增长10.72%;净利润3.27亿港元，同比增长4.77%;基本每股盈利19.26港仙。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告 全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 BRIGHT SMART SECURITIES & COMMODITIES GROUP LIMITED 耀才證券金融集團有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1428） 截至二零二五年九月三十日止六個月之中期業績公告 耀才證券金融集團有限公司（「本公司」連同其附屬公司，合稱「本集團」或「耀 才集團」）董事（「董事」）會（「董事會」）欣然公佈本集團截至二零二五年九月 三十日止六個月（「本期間」）之未經審核綜合業績，連同截至二零二四年九月 三十日止六個月之比較數字如下： 綜合全面收益表 截至二零二五年九月三十日止六個月 — 未經審核 （除另有指明外，以港元列示） | | | 截至九月三十日止六個月 | | | --- | --- | --- | --- | | | | 二零二五年 | 二零二四年 | | | 附註 | 千元 | 千元 | | 收入 | 4 | 496,876 | 448, ...

2025 年 11 月 26 日 可能強制全面要約 就耀才證券金融集團有限公司的股份的交易披露 完 註： Morgan Stanley Capital Services LLC 是與要約人有關連的第(5)類別聯繫人。 交易是為本身帳戶進行的。 Morgan Stanley Capital Services LLC 是最終由摩根士丹利擁有的公司。 交易披露 執行人員接獲依據香港《公司收購及合併守則》規則 22 作出以下的證券交易的披露： | 交易方 | 日期 | | | 有關證券的說明 | 產品說明 | 交易性質 | | 與衍生工具有 | 到期日或清結日 | | 參考價 | 已支付／已收取 | 交易後數額（包括 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | 關的參照證券 | | | | 的總金額 | 與其訂有協議或 | | | | | | | | | | 數目 | | | | | | 達成諒解的任何 | | | | | | | | ...

Morgan Stanley & Co., International plc 是與要約人有關連的第(5)類別聯繫人。 交易是為本身帳戶進行的。 Morgan Stanley & Co., International plc 是最終由摩根士丹利擁有的公司。 2025 年 11 月 26 日 交易披露 | 交易方 | 日期 | | | 有關證券的說 | 交易性質 | 買入／賣出 | 涉及的股份 | 已支付／已收取 | 已支付或已收 | | 已支付或已收 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 明 | | | 總數 | 的總金額 | 取的最高價 | 取的最低價 | | | | | | | | | | | | （H） | （L） | | | Morgan Stanley | 2025 | 11 年 | 月 | 普通股 | 因全屬客戶主動發出且由客戶需求帶動的買賣盤所 | 買入 | 80,000 | $600,538.0000 | $7.6300 | $7.3000 | | | & Co ...

2025 年 11 月 26 日 可能強制全面要約 註： Morgan Stanley & Co., International plc 是與要約人有關連的第(5)類別聯繫人。 就耀才證券金融集團有限公司的股份的交易披露 執行人員接獲依據香港《公司收購及合併守則》規則 22 作出以下的證券交易的披露： | 交易方 | 日期 | | | 有關證券的說明 | 產品說明 | 交易性質 | | 與衍生工具 | 到期日或清結日 | | 參考價 | | 已支付／已收 | 交易後數額（包括 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | 有關的參照 | | | | | 取的總金額 | 與其訂有協議或 | | | | | | | | | | | 證券數目 | | | | | | 達成諒解的任何 | | | | | | | | | | | | | | | | | 人士的證券） | | | Morgan Stanley | 2025 | 年 ...